Literature DB >> 35024248

Social prescribing and behaviour change: proposal of a new behaviour change technique concerning the 'connection' step.

Kathryn B Cunningham1, Rayna H Rogowsky2, Sharon A Carstairs1, Frank Sullivan1, Gozde Ozakinci1.   

Abstract

Entities:  

Year:  2022        PMID: 35024248      PMCID: PMC8747515          DOI: 10.1080/21642850.2021.2019584

Source DB:  PubMed          Journal:  Health Psychol Behav Med        ISSN: 2164-2850


× No keyword cloud information.
Social prescribing, also known as community referral, is gaining international recognition as a health and social care initiative with benefits for individuals (e.g. improving mental wellbeing), healthcare services (e.g. decreasing inpatient admissions), and societies (e.g. creating more inclusive communities) (Drinkwater, Wildman, & Moffatt, 2019; Global Social Prescribing Alliance, 2021). Further, it is being advocated as an advantageous tool to help facilitate recovery from the COVID-19 pandemic (Royal College of Psychiatrists, 2021). Social prescribing involves a health or social care professional connecting an individual with an appropriate community-based opportunity to improve that individual’s health (physical and/or mental) and wellbeing (physical, mental and/or social), for example, a local jogging group to increase physical activity levels, or a hobby club to reduce feelings of loneliness. The connection can be made via a direct route (health or social care professional connecting person to community-based opportunity) or an indirect route (health or social care professional connecting person to social prescribing professional – usually referred to as ‘link worker’ or ‘community connector’ – and social prescribing professional connecting person to community-based opportunity). Different methods of connection can be utilised: signposting, prescription or referral in a direct route, and a combination of these methods in an indirect route (Cunningham, Rogowsky, Carstairs, Sullivan, & Ozakinci, 2021). Social prescribing can therefore be conceptualised as a ‘system’ (Husk, Elston, Gradinger, Callaghan, & Asthana, 2019, p. 7) comprising two parts: (1) the community-based opportunities for health and wellbeing improvement; (2) the processes of connection from health or social care to those community-based opportunities (Cunningham et al., 2021; Husk et al., 2019). [S]ocial prescribing … creates the opportunity for real and lasting behaviour change. (Health Education England, 2016) Social prescribing is recognised as a useful approach for facilitating behaviour change (Health Education England, 2016). Behaviour change interventions employing social prescribing firstly enhance an individual’s motivation to change, then connect the individual with an appropriate community-based opportunity to assist with turning motivation into action. Social prescribing therefore deserves attention in the field of behaviour change. The connection step of behaviour change interventions employing social prescribing is not currently included in the widely-used Behaviour Change Technique (BCT) Taxonomy (Michie et al., 2013), nor in additional BCT taxonomies focussing on particular behavioural domains (e.g. the CALO-RE taxonomy for physical activity and health eating behaviours [Michie et al., 2011]). The inclusion of the connection step in these BCT taxonomies is warranted. The purpose of these BCT taxonomies is to facilitate development, implementation and evaluation of, and evidence synthesis regarding, behaviour change interventions by providing a standardised terminology to enable precise and clear specification and coding of the active ingredients of such interventions (BCTs) (Michie et al., 2013; Scott et al., 2020). The taxonomies currently contain BCTs enabling specification and coding of active ingredients employed to enhance an individual’s motivation to change, e.g. Information about health consequences, and active ingredients to assist with turning motivation into action, e.g. Instruction on how to perform a behaviour. However they do not contain a BCT enabling specification and coding of the connection step of behaviour change interventions employing social prescribing. This absence hinders comprehensive specification and coding of the active ingredients of such interventions. The taxonomies pre-date the recent upsurge of interest in social prescribing, thus this gap is unsurprising. Literature regarding the taxonomies acknowledges the need for them to be updated as new evidence emerges and new BCTs are identified: “We anticipate that further refinement and development of BCT Taxonomy v1 will occur as a result of its use and feedback from primary researchers, systematic reviewers and practitioners” (Michie et al., 2013, p. 93); “a descriptive taxonomy of BCTs is not written in stone. Additional iterations are needed to optimise reliability, comprehensiveness, theoretical coherence and relevance” (Michie et al., 2011, p. 1482). We therefore believe it timely – given the increasing momentum of social prescribing and its potential to facilitate recovery from the COVID-19 pandemic – to propose a new BCT enabling specification and coding of the connection step of behaviour change interventions employing social prescribing. We present this new BCT in the format of the BCT Taxonomy version 1 (Michie et al., 2013) in Table 1.
Table 1.

The label, definition and examples of the new BCT.

LabelDefinitionExamples
Connecting with community-based opportunityConnect the person with a community-based opportunity to facilitate performance of the desired behaviour via a direct or indirect route and using signposting, prescription, referral or a combination of these methodsFormally refer the person to a jogging group in the local communityProvide the person with an information leaflet about a weight loss support group and advise that they attend
The label, definition and examples of the new BCT. We envisage that this BCT will allow comprehensive specification and coding of the active ingredients of behaviour change interventions employing social prescribing. In doing so it will facilitate development, implementation and evaluation of, and evidence synthesis regarding, such interventions, thereby promoting progress in the fields of behaviour change and social prescribing. We recommend that this BCT be considered for inclusion in the BCT taxonomies as they are updated – we plan to engage with the team(s) responsible for the taxonomies regarding this, as suggested in published advice (Michie et al., 2013).
  6 in total

1.  A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy.

Authors:  Susan Michie; Stefanie Ashford; Falko F Sniehotta; Stephan U Dombrowski; Alex Bishop; David P French
Journal:  Psychol Health       Date:  2011-06-28

2.  Social prescribing.

Authors:  Chris Drinkwater; Josephine Wildman; Suzanne Moffatt
Journal:  BMJ       Date:  2019-03-28

3.  Social prescribing: where is the evidence?

Authors:  Kerryn Husk; Julian Elston; Felix Gradinger; Lynne Callaghan; Sheena Asthana
Journal:  Br J Gen Pract       Date:  2019-01       Impact factor: 5.386

Review 4.  Methods of connecting primary care patients with community-based physical activity opportunities: A realist scoping review.

Authors:  Kathryn B Cunningham; Rayna H Rogowsky; Sharon A Carstairs; Frank Sullivan; Gozde Ozakinci
Journal:  Health Soc Care Community       Date:  2020-10-19

5.  The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions.

Authors:  Susan Michie; Michelle Richardson; Marie Johnston; Charles Abraham; Jill Francis; Wendy Hardeman; Martin P Eccles; James Cane; Caroline E Wood
Journal:  Ann Behav Med       Date:  2013-08

6.  Using the behaviour change technique taxonomy v1 (BCTTv1) to identify the active ingredients of pharmacist interventions to improve non-hospitalised patient health outcomes.

Authors:  Claire Scott; Mícheál de Barra; Marie Johnston; Marijn de Bruin; Neil Scott; Catriona Matheson; Christine Bond; Margaret C Watson
Journal:  BMJ Open       Date:  2020-09-15       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.